Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-16

Clinical Trial Update: Safety and Efficacy of Inhaled Cannabis For the Uncontrolled Pain Relief in Patients With Advanced Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing safety and efficacy of inhaled cannabis for uncontrolled pain relief in patients with advanced cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inhaled cannabis (cannabis)

Snippet

Sponsor: Tetra Bio-Pharma | Conditions: Cancer Pain, Quality of Life | Phase 2 | Status: UNKNOWN